Biovirtus Research Sitesp. z o.o. in liquidation

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-01-18
Share capital
100,000.00 PLN
Registered address
ul. Augustyna Locciego 5/2, 02-928 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 529 days for 2020).

  • 202511/07/2026
  • 202410/07/2025
  • 202303/07/2024
  • 202217/07/2023
  • 202103/10/2022
  • 202028/03/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,429 / 1,950
Top 73%
Voivodeship · Mazowieckie114,923 / 142,095
Top 81%
Country · Poland410,004 / 496,043
Top 83%

Results vs industry

Revenue
This companyUSD 9.33kMedianUSD 56.20kAverageUSD 2.71m
Net profit
This companyUSD -31.13kMedianUSD -1.27kAverageUSD -92.39k
Operating costs
This companyUSD 39.40kMedianUSD 66.19kAverageUSD 2.67m
Assets
This companyUSD 382.47kMedianUSD 133.95kAverageUSD 3.03m

National Health Fund (NFZ) contracts

Biovirtus Research Site has been an NFZ healthcare provider since 2015. In 2024 it is performing 2 contracts with a total value of USD 16.87k. All its contracts were worth USD 94.80k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2024
Podstawowa Opieka Zdrowotnamazowieckie1USD 16.87k
Pilot programmesmazowieckie1USD 0.00

Trademarks

Biovirtus Research Site holds 4 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.

MarkNumberClassesStatusProtected until
BioVirtus Research SiteZ.48773442, 44Protected Jul 2, 2028
BioVirtus(word)Z.46709842, 44Protected Feb 3, 2027
BioVirtus Research Site(word)Z.46709942, 44Protected Feb 3, 2027
Bio VirtusZ.46709642, 44Protected Feb 3, 2027
Bio Virtus Research SiteZ.46709742, 44Not registered –
MarkProtected until
BioVirtus Research SiteJul 2, 2028
BioVirtus(word)Feb 3, 2027
BioVirtus Research Site(word)Feb 3, 2027
Bio VirtusFeb 3, 2027
Bio Virtus Research Site–

Authorized Representatives

Marek Norbert Zdanowicz – Liquidator

Ownership

OwnerSharesShare valueStake
1,000$27,012.43100%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Mar 3, 2023Call to creditors
Mar 3, 2023Call to creditors

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,816
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,286
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,100

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Frontline BiosciencesS.A.
AI Corelabsp. z o.o.
ModicaP.S.A.
WPD Pharmaceuticalssp. z o.o.
WPD PharmaceuticalsS.A.
Stenocoatsp. z o.o.
Platforma Badań Genetycznychsp. z o.o.
Bioselsp. z o.o.
Omnisepticasp. z o.o.
Wavex Energysp. z o.o.

Change history

DateEvent
2023-01-11Name change
2022-12-29Liquidation opened
2017-02-22Address change
2016-08-17PKD change
2016-04-18PKD change

FAQ

Last updated: 2026-10-04